Literature DB >> 19668780

Time from first medical contact to reperfusion in ST elevation myocardial infarction: a Which Early ST Elevation Myocardial Infarction Therapy (WEST) substudy.

Iqbal Bata1, Paul W Armstrong, Cynthia M Westerhout, Andrew Travers, Sunil Sookram, Edward Caine, James Christenson, Robert C Welsh.   

Abstract

BACKGROUND: Recent research and contemporary ST elevation myocardial infarction guidelines emphasize the importance of prompt reperfusion and have redefined the traditional time to treatment metric to include prehospital paramedical staff as the point of first medical contact. However, an important knowledge gap exists relating to data systematically addressing the impact of arrival at the hospital by ambulance and the delays inherent in transfer from a community hospital to tertiary centres for percutaneous coronary intervention (PCI).
METHODS: The Which Early ST Elevation Myocardial Infarction Therapy (WEST) study initiated treatment at the point of first medical contact, including prehospital contact. Patients were randomly assigned to receive fibrinolysis with usual care or coupled with mechanical cointervention, or primary PCI. To assess the impact of this strategy on time to treatment, the following randomly assigned patient groups were compared: prehospital versus in-hospital; those arriving at the hospital by ambulance versus ambulatory self transport; and those whose initial hospital care was a community versus PCI centre.
RESULTS: Of the 328 patients enrolled in the study, 221 received fibrinolysis and 107 received primary PCI. Compared with the in-hospital group, patients who underwent prehospital random assignment (44%, n=145) experienced a 48 min reduction in median (interquartile range) time from symptom onset to first study medication (87 min [65 min to 147 min] versus 135 min [95 min to 186 min]; P<0.001) and a 56 min reduction in time to first balloon inflation (148 min [117 min to 214 min] versus 204 min [166 min to 290 min]; P<0.001). Arrival by ambulance without prehospital random assignment (n=90) incurred a substantial delay from first medical contact to reperfusion (fibrinolysis 76 min [63 min to 105 min] and PCI 160 min [141 min to 212 min]) compared with prehospital random assignment (n=145; fibrinolysis 43 min [33 min to 54 min] and PCI 105 min [90 min to 127 min]) or ambulatory patients (n=93; fibrinolysis 47 min [32 min to 68 min] and PCI 108 min [85 min to 150 min]). Community (n=165) versus PCI hospital (n=163) random assignment was associated with a longer delay from first medical contact to reperfusion: fibrinolysis, 56 min versus 47 min (P=0.008) and primary PCI, 139 min versus 105 min (P=0.001). DISCUSSION: Prehospital diagnosis, random assignment and treatment substantially reduced treatment delay with both pharmacological and mechanical reperfusion. Those activating the prehospital medical response system without receiving prehospital random assignment experienced the longest delay from first medical contact to reperfusion, indicating a lost opportunity to enhance ST elevation myocardial infarction patient outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19668780      PMCID: PMC2732387          DOI: 10.1016/s0828-282x(09)70118-7

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  20 in total

1.  The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4.

Authors:  Jeptha P Curtis; Edward L Portnay; Yongfei Wang; Robert L McNamara; Jeph Herrin; Elizabeth H Bradley; David J Magid; Martha E Blaney; John G Canto; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2006-03-29       Impact factor: 24.094

2.  Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?

Authors:  Brahmajee K Nallamothu; Eric R Bates
Journal:  Am J Cardiol       Date:  2003-10-01       Impact factor: 2.778

3.  A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction.

Authors:  Timothy D Henry; Scott W Sharkey; M Nicholas Burke; Ivan J Chavez; Kevin J Graham; Christopher R Henry; Daniel L Lips; James D Madison; Katie M Menssen; Michael R Mooney; Marc C Newell; Wes R Pedersen; Anil K Poulose; Jay H Traverse; Barbara T Unger; Yale L Wang; David M Larson
Journal:  Circulation       Date:  2007-08-01       Impact factor: 29.690

4.  Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol.

Authors:  Henry H Ting; Charanjit S Rihal; Bernard J Gersh; Luis H Haro; Christine M Bjerke; Ryan J Lennon; Choon-Chern Lim; John F Bresnahan; Allan S Jaffe; David R Holmes; Malcolm R Bell
Journal:  Circulation       Date:  2007-08-01       Impact factor: 29.690

5.  Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial.

Authors:  R C Welsh; W Chang; P Goldstein; J Adgey; C B Granger; F W A Verheugt; L Wallentin; F Van de Werf; P W Armstrong
Journal:  Heart       Date:  2005-03-17       Impact factor: 5.994

6.  Strategies for reducing the door-to-balloon time in acute myocardial infarction.

Authors:  Elizabeth H Bradley; Jeph Herrin; Yongfei Wang; Barbara A Barton; Tashonna R Webster; Jennifer A Mattera; Sarah A Roumanis; Jeptha P Curtis; Brahmajee K Nallamothu; David J Magid; Robert L McNamara; Janet Parkosewich; Jerod M Loeb; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

7.  Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis.

Authors:  Brahmajee K Nallamothu; Eric R Bates; Jeph Herrin; Yongfei Wang; Elizabeth H Bradley; Harlan M Krumholz
Journal:  Circulation       Date:  2005-02-07       Impact factor: 29.690

8.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction).

Authors:  Elliott M. Antman; Daniel T. Anbe; Paul Wayne Armstrong; Eric R. Bates; Lee A. Green; Mary Hand; Judith S. Hochman; Harlan M. Krumholz; Frederick G. Kushner; Gervasio A. Lamas; Charles J. Mullany; Joseph P. Ornato; David L. Pearle; Michael A. Sloan; Sidney C. Smith; Joseph S. Alpert; Jeffrey L. Anderson; David P. Faxon; Valentin Fuster; Raymond J. Gibbons; Gabriel Gregoratos; Jonathan L. Halperin; Loren F. Hiratzka; Sharon Ann Hunt; Alice K. Jacobs; Joseph P. Ornato
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

9.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial.

Authors:  W D Weaver; M Cerqueira; A P Hallstrom; P E Litwin; J S Martin; P J Kudenchuk; M Eisenberg
Journal:  JAMA       Date:  1993-09-08       Impact factor: 56.272

10.  Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events.

Authors:  B Nallamothu; K A A Fox; B M Kennelly; F Van de Werf; J M Gore; P G Steg; C B Granger; O H Dabbous; E Kline-Rogers; K A Eagle
Journal:  Heart       Date:  2007-06-25       Impact factor: 5.994

View more
  3 in total

Review 1.  Pre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarction.

Authors:  Michael McCaul; Andrit Lourens; Tamara Kredo
Journal:  Cochrane Database Syst Rev       Date:  2014-09-10

2.  Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.

Authors:  Karl Heinrich Scholz; Sebastian K G Maier; Lars S Maier; Björn Lengenfelder; Claudius Jacobshagen; Jens Jung; Claus Fleischmann; Gerald S Werner; Hans G Olbrich; Rainer Ott; Harald Mudra; Karlheinz Seidl; P Christian Schulze; Christian Weiss; Josef Haimerl; Tim Friede; Thomas Meyer
Journal:  Eur Heart J       Date:  2018-04-01       Impact factor: 29.983

3.  Effect of Covid-19 pandemic process on STEMI patients timeline.

Authors:  Korhan Soylu; Metin Coksevim; Ahmet Yanık; Idris Bugra Cerik; Gökhan Aksan
Journal:  Int J Clin Pract       Date:  2021-01-21       Impact factor: 3.149

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.